Table 2.
KDIGO stage at initial presentation and during admission in relation to serum and urine NGAL and urine KIM-1 for all six patients with AKI
| KDIGO stage at presentation | Highest KDIGO stage during admission | RRTa | Serum NGAL (≤177 ng/ml) | Urine NGAL (≤72 ng/ml) | Urine KIM-1 (≤5.33 ng/ml) |
|---|---|---|---|---|---|
| 0 | 3 | Yes | 899 | 22,028 | 1.84 |
| 0 | 3 | No | 501 | 8691 | 3.88 |
| 1 | 2 | No | 174 | 376 | 4.40 |
| 2 | 2 | No | 2287 | 6452 | 3.92 |
| 2 | 3 | Yes | 205 | 5132 | 3.87 |
| 3 | 3 | Yes | 2014 | 838 | 7.75 |
Italics: Elevated laboratory measurements
Reference ranges in brackets
aRenal replacement therapy